Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ⅲ Placebo-controlled Study of NPO-11 in Chinese Patients Undergoing Gastrointestinal Endoscopy

NCT03263910 is registered in ClinicalTrials.gov with Nihon Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT03263910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03263910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ⅲ Placebo-controlled Study of NPO-11 in Chinese Patients Undergoing Gastrointestinal Endoscopy
Lead sponsor
Nihon Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
August 21, 2017
Completion date
August 17, 2018
Enrollment
220 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

patients undergoing gastrointestinal endoscopy